We look for answers in unexpected places & vigorously test our hypotheses to deliver ground-breaking advances to patients.
Careful Planning for Success
Inmedix specializes in understanding how stress drives an autoimmune disease to excess.
For our first patented project, fibromyalgia (FM), we conducted three clinical studies, including a randomized, placebo-controlled
For our second project, we found actionable biomarkers based on human electrical signals (ECG) using our innovative and patent-protected 'e-laboratory' in the Azure cloud. Inmedix is defining Immuno-autonomics and seeks to improve
We conducted 15 years of research, including a 52-week, double-blind, proof-of-concept study before creating our lead
Inmedix is a privately held corporation (DE) that seeks like-minded individuals and institutions to support our mission of significantly enhancing established therapies for autoimmune disease through assessment, optimization and